Contrary to the prolonged silent phase of asymptomatic amyloidosis6–12, standard APP transgenic overexpression models with high levels of APP and Aβ expression develop early synaptic dysfunction and dementia-like deficits before the onset of Aβ pathology31,32, a disease stage never observed in humans. This evidence concerns the gene APP and dementia.